AstraZeneca Funds NIH Network Studying Drug-Induced Liver Injuries

AstraZeneca is providing an unspecified sum of money to support the National Institutes of Health's Drug-Induced Liver Injury Network, making the firm the first corporate sponsor of what NIH hopes will be many